{{ variable.name }}
【Indications】
This product is indicated for the treatment of diarrhea-predominant irritable bowel syndrome(IBS-D)in adult patients.
【Recommended Dose】
If symptoms continue to improve with this medication,it should not be used indefinitely.Consideration should be given to continuing or discontinuing treatment approximately 3 months after initiating therapy.
Male diarrhea-predominant IBS:
Typically,5 mcg per dose,orally,once daily.The dose may be adjusted based on symptoms,but the maximum daily dose should not exceed 10 mcg.
Female diarrhea-predominant IBS:
Typically,2.5 mcg per dose,orally,once daily.If efficacy is insufficient,the dose may be increased,but the maximum daily dose should not exceed 5 mcg.
【Adverse Reactions】
The main adverse reactions(≥5%)are constipation and hard stools.
【Pharmacology】
Blocking 5-HT3 receptors inhibits increased intestinal motility and diarrhea,as well as the hypersensitivity reaction to colonic pain.
【Storage】
Store protected from light,in a tightly sealed container,at room temperature.